🕵️ FATE Therapeutics Inc ($FATE)
SEC insider & ownership activity, last 12 months · CIK 1434316 · every row links its SEC filing
Over the last 12 months insiders sold $144K with no open-market buying against it. Valamehr Bahram sold $75K in discretionary trades (Aug–May). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 2 sellers, $144K (6 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Valamehr Bahram | 0 | – | 3 | $75K | May 20, 2026 |
| Tahl Cindy | 0 | – | 3 | $69K | May 20, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Redmile Group, LLC | 14.9% | 13D | Apr 20, 2026 | filing ↗ | |
| Jeremy C. Green | 14.9% | 13D | Apr 20, 2026 | filing ↗ | |
| Redmile Group, LLC | 14.9% | 13D | Dec 20, 2024 | filing ↗ | |
| Jeremy C. Green | 14.9% | 13D | Dec 20, 2024 | filing ↗ | |
| Redco II Offshore SPV LLC | 8.5% | 13D | Apr 20, 2026 | filing ↗ | |
| Redco II Master Fund, L.P. | 8.5% | 13D | Dec 20, 2024 | filing ↗ | |
| Blackrock, Inc. | exited | 13G | Jul 8, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Valamehr Bahram | $54K | May 20, 2026 | filing ↗ |
| Tahl Cindy | $48K | May 20, 2026 | filing ↗ |
| Tahl Cindy | $11K | Jan 9, 2026 | filing ↗ |
| Valamehr Bahram | $6K | Jan 9, 2026 | filing ↗ |
| Mendlein John | $39K | Dec 24, 2025 | filing ↗ |
| Tahl Cindy | $10K | Aug 4, 2025 | filing ↗ |
| Valamehr Bahram | $15K | Aug 4, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jun 12, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 12, 2026 | filing ↗ |
| Other events (8.01) | Jun 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 4, 2026 | filing ↗ |
| Earnings (2.02) | May 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 13, 2026 | filing ↗ |
| Earnings (2.02) | Feb 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing ↗ |
| Earnings (2.02) | Nov 13, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 13, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 26, 2025 | filing ↗ |
| Other events (8.01) | Oct 26, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 26, 2025 | filing ↗ |
| Officer/director changes (5.02) | Oct 10, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 10, 2025 | filing ↗ |
| Earnings (2.02) | Aug 7, 2025 | filing ↗ |
| Exit or disposal costs (2.05) | Aug 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 7, 2025 | filing ↗ |